Track topics on Twitter Track topics that are important to you
Tuesday, September 12th 2017 at 6:00am UTC PARIS–(BUSINESS WIRE)– Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, today announced that portfolio company DNA Script, an industry leader in the manufacture of de novo synthetic nucleic acids using proprietary enzymatic technology, has raised €11 million. Sofinnova Partners is DNA Script’s historic and …
Cet article Sofinnova Partners Announces DNA Script’ Successful Series A
Fundraising of €11 M to Advance Development of Its DNA Synthesis
Technology est apparu en premier sur EEI-BIOTECHFINANCES.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...